🇺🇸 FDA
Patent

US 11844830

Vaccines for human papilloma virus and methods for using the same

granted A61KA61K2039/53A61K2039/54

Quick answer

US patent 11844830 (Vaccines for human papilloma virus and methods for using the same) held by Inovio Pharmaceuticals, Inc. expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/53, A61K2039/54, A61K2039/70, A61K39/12